1. Home
  2. MPB vs PCRX Comparison

MPB vs PCRX Comparison

Compare MPB & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid Penn Bancorp

MPB

Mid Penn Bancorp

HOLD

Current Price

$36.83

Market Cap

827.5M

Sector

Finance

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$24.61

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPB
PCRX
Founded
1868
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
827.5M
1.1B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
MPB
PCRX
Price
$36.83
$24.61
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$37.00
$30.25
AVG Volume (30 Days)
70.5K
432.4K
Earning Date
04-21-2026
04-30-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
107.44
EPS
1.22
0.19
Revenue
N/A
$541,533,000.00
Revenue This Year
$30.95
$6.78
Revenue Next Year
$9.45
$8.54
P/E Ratio
$30.16
$128.84
Revenue Growth
N/A
26.04
52 Week Low
$26.56
$18.80
52 Week High
$39.15
$27.66

Technical Indicators

Market Signals
Indicator
MPB
PCRX
Relative Strength Index (RSI) 46.02 45.26
Support Level $35.87 $24.61
Resistance Level $37.37 $27.05
Average True Range (ATR) 0.75 0.73
MACD -0.04 -0.17
Stochastic Oscillator 47.06 30.67

Price Performance

Historical Comparison
MPB
PCRX

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc is a financial holding company, providing various banking and financial products and services through its subsidiaries. These products and services mainly include consumer banking products, including secure checking and savings accounts, mobile banking, agricultural loans, construction financing, mortgages, home equity loans and lines of credit, credit cards, and more. Additionally, the Group offers trust services, insurance products, wealth management, and private banking services. The Group caters to individuals, partnerships, non-profit organizations, and corporations through its retail banking offices located throughout Pennsylvania, with a minor portion in New Jersey.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: